Sweden has long been recognized for its innovative and ethically driven healthcare model. Recently, the country has emerged as a leader in the study of Ibogaine TA and Psilocybin, two compounds that hold promise for mental health treatment and neurotherapeutic innovation. This movement reflects Sweden’s commitment to evidence-based approaches, patient safety, and ethical biotech practices. […]